{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T14:46:55Z","timestamp":1743346015724,"version":"3.37.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09480-y","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T13:01:51Z","timestamp":1712754111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BRAF and RET polymorphism association with thyroid cancer risk, a preliminary study from Khyber Pakhtunkhwa population"],"prefix":"10.1007","volume":"51","author":[{"given":"Maryam","family":"Batool","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najeeb Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhlid H.","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ijaz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"9480_CR1","doi-asserted-by":"crossref","unstructured":"Ghazy E et al (2021) Scrutinizing the therapeutic and diagnostic potential of nanotechnology in thyroid cancer: edifying drug targeting by nano-oncotherapeutics. 61:102221","DOI":"10.1016\/j.jddst.2020.102221"},{"key":"9480_CR2","first-page":"102","volume":"11","author":"A Prete","year":"2020","unstructured":"Prete A et al (2020) Update Fundamental Mech Thyroid cancer 11:102","journal-title":"Update Fundamental Mech Thyroid cancer"},{"key":"9480_CR3","doi-asserted-by":"crossref","unstructured":"Figlioli G et al (2013) Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. 752(1):36\u201344","DOI":"10.1016\/j.mrrev.2012.09.002"},{"key":"9480_CR4","doi-asserted-by":"crossref","unstructured":"Miranda-Filho A et al (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. 9(4):225\u2013234","DOI":"10.1016\/S2213-8587(21)00027-9"},{"key":"9480_CR5","doi-asserted-by":"crossref","unstructured":"Niaz M et al (2021) Incident of thyroid carcinomas and other pathologies with age correlation in patients presented with palpable thyroid masses undergoing thyroidectomies. 15(1):77\u201381","DOI":"10.29054\/apmc\/2021.733"},{"key":"9480_CR6","doi-asserted-by":"crossref","unstructured":"Allen M et al (2021) Tracheal Resection in the Management of Thyroid Cancer: An Evidence-Based Approach 131(4): pp. 932\u2013946","DOI":"10.1002\/lary.29112"},{"key":"9480_CR7","doi-asserted-by":"crossref","unstructured":"Hyun JW, Song HJ, J.H.J.J.o.K.B.N S, Choi (2021) Associations of illness symptoms, perception of illness, and coping with quality of life of thyroid cancer patients after thyroidectomy. 23(1):83\u201390","DOI":"10.7586\/jkbns.2021.23.1.83"},{"issue":"19","key":"9480_CR8","first-page":"1575","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C et al (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. Int RET Mutat Consortium Anal 276(19):1575\u20131579","journal-title":"Int RET Mutat Consortium Anal"},{"key":"9480_CR9","doi-asserted-by":"crossref","unstructured":"de Groot JWB et al (2006) RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. 27(5):535\u2013560","DOI":"10.1210\/er.2006-0017"},{"key":"9480_CR10","doi-asserted-by":"crossref","unstructured":"Lodish MB (2008) And C.A.J.E.r.o.a.t. Stratakis, RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer. 8(4):625\u2013632","DOI":"10.1586\/14737140.8.4.625"},{"key":"9480_CR11","doi-asserted-by":"crossref","unstructured":"Romei C, Ciampi R, Elisei RJNRE (2016) A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. 12(4):192","DOI":"10.1038\/nrendo.2016.11"},{"key":"9480_CR12","first-page":"S37","volume":"21","author":"YEJMP Nikiforov","year":"2008","unstructured":"Nikiforov YEJMP (2008) Thyroid Carcinoma: Mol Pathways Therapeutic Targets 21:S37\u2013S43","journal-title":"Thyroid Carcinoma: Mol Pathways Therapeutic Targets"},{"key":"9480_CR13","doi-asserted-by":"crossref","unstructured":"Machens A et al (2018) Genotype-specific progression of hereditary medullary thyroid cancer. 39(6):860\u2013869","DOI":"10.1002\/humu.23430"},{"key":"9480_CR14","doi-asserted-by":"crossref","unstructured":"Milos IN et al (2008) Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC\u2009>\u2009TGG) mutation. 15(4):1035\u20131041","DOI":"10.1677\/ERC-08-0105"},{"key":"9480_CR15","doi-asserted-by":"crossref","unstructured":"Crispo F et al (2019) BRAF inhibitors in thyroid cancer: clinical impact, mechanisms of resistance and future perspectives. 11(9):1388","DOI":"10.3390\/cancers11091388"},{"key":"9480_CR16","unstructured":"Oikonomou E, Pintzas AJAr (2006) Cancer genetics of sporadic colorectal cancer: BRAF and PI3KCA mutations, their impact on signaling and novel targeted therapies. 26(2A):1077\u20131084"},{"key":"9480_CR17","doi-asserted-by":"crossref","unstructured":"Asati V, Mahapatra DK (2016) and S.K.J.E.j.o.m.c. Bharti, PI3K\/Akt\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives 109: pp. 314\u2013341","DOI":"10.1016\/j.ejmech.2016.01.012"},{"key":"9480_CR18","doi-asserted-by":"crossref","unstructured":"Abdul-Hameed H et al (2023) Molecular study of BRAF gene polymorphisms and the association with mtDNA copy number in thyroid cancer. 30(4):489\u2013495","DOI":"10.47750\/jptcp.2023.30.04.047"},{"key":"9480_CR19","doi-asserted-by":"crossref","unstructured":"Qi T et al (2021) Somatic mutation profiling of papillary thyroid carcinomas by whole-exome sequencing and its relationship with clinical characteristics. 18(12):2532","DOI":"10.7150\/ijms.50916"},{"key":"9480_CR20","doi-asserted-by":"crossref","unstructured":"Liu X et al (2014) TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. 99(6):E1130\u2013E1136","DOI":"10.1210\/jc.2013-4048"},{"key":"9480_CR21","doi-asserted-by":"crossref","unstructured":"Eng ZH et al (2023) Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer. 10:1237548","DOI":"10.3389\/fmolb.2023.1237548"},{"key":"9480_CR22","doi-asserted-by":"crossref","unstructured":"Frank-Raue K et al (1996) Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German medullary thyroid Carcinoma Study Group. 81(5):1780\u20131783","DOI":"10.1210\/jc.81.5.1780"},{"key":"9480_CR23","doi-asserted-by":"crossref","unstructured":"Sarkadi B et al (2019) Germline BRCA1 mutation detected in a multiple endocrine neoplasia type 2 Case with RET Codon 634 mutation. 10:544","DOI":"10.3389\/fgene.2019.00544"},{"issue":"1","key":"9480_CR24","first-page":"227","volume":"50","author":"M Jehanzeb","year":"2023","unstructured":"Jehanzeb M et al (2023) Association of candidate genes (ALR2, RAGE, and VEGF) polymorphisms with diabetic retinopathy in type 2 diabetic patients of Khyber Pakhtunkhwa. Pakistan 50(1):227\u2013234","journal-title":"Pakistan"},{"key":"9480_CR25","doi-asserted-by":"crossref","unstructured":"Khan Y et al (2023) Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in pashtun population of Khyber Pakhtunkhwa. Pakistan : p. 1\u201310","DOI":"10.21203\/rs.3.rs-2625327\/v1"},{"key":"9480_CR26","doi-asserted-by":"crossref","unstructured":"Shahzad S et al (2023) Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa. 50(3):2445\u20132451","DOI":"10.1007\/s11033-022-08198-z"},{"issue":"1","key":"9480_CR27","first-page":"1","volume":"51","author":"A Ullah","year":"2024","unstructured":"Ullah A et al (2024) Assessment of HER1 (rs11543848) and HER2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa. Pakistan 51(1):1","journal-title":"Pakistan"},{"key":"9480_CR28","doi-asserted-by":"crossref","unstructured":"Nisar A et al (2022) Fyn and Lyn gene polymorphisms impact the risk of thyroid cancer. 297(6):1649\u20131659","DOI":"10.1007\/s00438-022-01946-7"},{"key":"9480_CR29","doi-asserted-by":"crossref","unstructured":"Pellegriti G et al (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors 2013","DOI":"10.1155\/2013\/965212"},{"issue":"5","key":"9480_CR30","first-page":"1191","volume":"18","author":"E Younis","year":"2017","unstructured":"Younis E (2017) J.A.P.j.o.c.p.A. Oncog Thyroid cancer 18(5):1191","journal-title":"Oncog Thyroid cancer"},{"key":"9480_CR31","doi-asserted-by":"crossref","unstructured":"Takahashi M, Kawai K, Asai NJJj (2020) Roles of the RET proto-oncogene in cancer and development. 3(3):175\u2013181","DOI":"10.31662\/jmaj.2020-0021"},{"key":"9480_CR32","doi-asserted-by":"crossref","unstructured":"Rashid FA et al (2022) Variations in MAP kinase gladiators and risk of differentiated thyroid carcinoma. 16(2):1\u201312","DOI":"10.3892\/mco.2021.2478"},{"key":"9480_CR33","doi-asserted-by":"crossref","unstructured":"Abdelhakim A et al (2009) RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience. 5(3):198\u2013202","DOI":"10.4103\/0973-1482.57126"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09480-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:51:42Z","timestamp":1738702302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09480-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9480"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09480-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"1 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was taken from the Institute of Biotechnology and Genetic Engineering (IBGE), The University of Agriculture Peshawar, Pakistan under (IBGE\/2022\/016). Written informed consent was obtained from all the participants after the aim of the study was explained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and approved the article for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors reviewed and authorized the final manuscript and agreed to publish it.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors declaration"}}],"article-number":"502"}}